Table 4 Cost and effectiveness of three strategies for tuberculosis control in Zambian newborns over 30 years, for the total cohort of 468,073 newborns
From: Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
Strategies | Total Costs | Direct Costs | Indirect Costs | TB Cases | TB Mortality | |
|---|---|---|---|---|---|---|
Ranked from least to most expensive with respect to total cost | $ million | $ million | $ million | Â | Â | |
After 5 years | Novel TB vaccine at birth | 7.123 | 3.348 | 3.775 | 5,771 | 2,861 |
| Â | Status quo | 8.154 | 3.539 | 4.615 | 6,643 | 3,215 |
| Â | Novel TB vaccine at birth with Booster | 8.347 | 4.572 | 3.775 | 5,771 | 2,861 |
After 10 years | Novel TB vaccine at birth | 16.702 | 5.721 | 10.981 | 11,608 | 6,452 |
| Â | Novel TB vaccine at birth with Booster | 17.926 | 6.945 | 10.981 | 11,608 | 6,452 |
| Â | Status quo | 18.754 | 5.980 | 12.774 | 12,592 | 6,896 |
After 20 years | Novel TB vaccine at birth with Booster | 36.486 | 10.129 | 26.357 | 19,388 | 12,772 |
| Â | Novel TB vaccine at birth | 37.459 | 9.330 | 28.129 | 20,366 | 13,380 |
| Â | Status quo | 40.463 | 9.583 | 30.880 | 21,305 | 13,808 |
After 30 years | Novel TB vaccine at birth with Booster | 50.876 | 11.930 | 38.946 | 23,694 | 17,368 |
| Â | Novel TB vaccine at birth | 52.863 | 11.126 | 41.737 | 24,625 | 17,957 |
| Â | Status quo | 56.481 | 11.377 | 45.104 | 25,557 | 18,379 |